O56 SOFOSBUVIR/LEDIPASVIR WITH AND WITHOUT RIBAVIRIN FOR 8 WEEKS COMPARED TO SOFOSBUVIR/LEDIPASVIR FOR 12 WEEKS IN TREATMENT-NAÏVE NON-CIRRHOTIC GENOTYPE-1 HCV-INFECTED PATIENTS: THE PHASE 3 ION-3 STUDY

Authors:
  • KKK.V. Kowdley
    K.V. Kowdley
  • GSG.C. Stuart
    G.C. Stuart
  • RRR.K. Reddy
    R.K. Reddy
  • LRL. Rossaro
    L. Rossaro
  • DBD.E. Bernstein
    D.E. Bernstein
  • DAD. An
    D. An
  • ESE.S. Svarovskaia
    E.S. Svarovskaia
  • RHR.H. Hyland
    R.H. Hyland
  • PPP.S. Pang
    P.S. Pang
  • WSW.T. Symonds
    W.T. Symonds
  • AMA.J. Muir
    A.J. Muir

Abstract
No abstract available